Sandison Taylor 4
4 · Cidara Therapeutics, Inc. · Filed Feb 11, 2020
Insider Transaction Report
Form 4
Sandison Taylor
Chief Medical Officer
Transactions
- Exercise of In-Money
Common Stock
2020-02-10$2.51/sh+6,115$15,349→ 73,331 total - Exercise of In-Money
Subscription Rights (right to buy)
2020-02-10−6,115→ 0 totalExercise: $2.51From: 2020-01-22Exp: 2020-02-10→ Common Stock (6,115 underlying) - Exercise of In-Money
Common Stock
2010-02-07$2.51/sh+4,594$11,531→ 67,216 total - Exercise of In-Money
Subscription Rights (right to buy)
2020-02-07−4,594→ 0 totalExercise: $2.51From: 2020-01-22Exp: 2020-02-10→ Common Stock (4,594 underlying)
Footnotes (2)
- [F1]Exercise of irrevocable subscription rights to acquire shares of Common Stock after the completion of the subscription period of Issuer's rights offering on February 10, 2020.
- [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2019.